SPY330.65-3.85 -1.15%
DIA276.52-2.38 -0.85%
IXIC10,793.28-117.00 -1.07%

Zai Lab, Novocure Reports First Patient Enrolled In Phase 2 Pilot Trial Evaluating Safety, Efficacy Of Tumor Treating Fields In Combo With Chemo

Benzinga · 01/09/2020 12:31